case studies
Revelle Aesthetics
Smartly solving cellulite: The launch of Revelle Aesthetics and Aveli
Almost every woman on earth (90%) has cellulite, but that doesn’t stop many of them from feeling embarrassed and uncomfortable in their own skin. Avéli received FDA approval in Spring 2022 at a time when so many women and doctors were disappointed in the lack of effective cellulite treatments in the market. Avéli is a new device that is designed for the long-term reduction in the appearance of cellulite on the buttocks in thighs in a single in-office visit with little-to-no downtime. Due to industry-wide skepticism of other cellulite treatments in the market, the parent company (Silicon Valley-based startup Revelle Aesthetics) wanted to launch Avéli in a smart, systematic and targeted approach. Primary objectives included raising awareness among women (ages 30-49), driving education, and boosting provider and patient growth.
case studies | revelle aesthetics
Results
Our Approach
- Develop tools and resources for US plastic surgeons and dermatologists to better understand and promote Avéli in the press and their practice social platforms
- Leverage key doctor KOLs as media spokespeople and on social content to drive education, trust and understanding
- Conduct targeted media outreach to top consumer and lifestyle outlets
- Establish credentials and build a presence for Revelle at industry trade shows; conduct outreach to key trade media outlets
- Build an inspiring, welcoming community on social media for women to learn about Avéli and share their cellulite journey - with providers also documenting real-life successes
- Support provider network by driving awareness, leads and conversions among patients through a geo-targeted paid search and paid media campaign
Featured in:
